Discordant biochemical parameters of acromegaly remission do not influence the prevalence or aggressiveness of metabolic comorbidities: a single-center study.

Front Endocrinol (Lausanne) · 2023 · PMC10565344 · PMID 37829686

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

near to significanceno p-value reported

( 22 ), who divided patients in controlled/high GH/high IGF-1/active disease, did not describe differences in the prevalence of comorbidities except for a trend of higher prevalence of diabetes in active disease and “high IGF-1” near to significance.

also in 14 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.